To test ISO treatment as stimulus is able to increase circulating Gal-3 levels in the Mst1-TG cardiomyopathy model, Mst1-TG mice were treated with ISO (6 mg/kg/day for 48 h). This evidence concerns the gene MST1 and cardiomyopathy.